Yayın: Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia
Dosyalar
Tarih
Kurum Yazarları
Ali, Rıdvan
Özkalemkaş, Fahir
Özkocaman, Vildan
Özkan, Atilla
Özçelik, Tülay
Tunalı, Ahmet
Yazarlar
Beksaç, Meral
Danışman
Dil
Türü
Yayıncı:
Taylor
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Özet
We read with great interest the article by Finneganet al. [1] in a recent issue ofLeukemia & Lymphoma,describing the results of primary plasma cell leukemia(PPCL) treated with bortezomib. We would like todescribe and share our experience in a patient withsecondary plasma cell leukemia (SPCL), who wassuccessfully treated with a combination of one doseof bortezomib, doxorubicin and dexamethasone, andin whom complete remission was maintained withthe administration of a single dose of bortezomibevery 3 weeks.
Açıklama
Kaynak:
Anahtar Kelimeler:
Konusu
Multiple-myeloma cells, Agents, Therapy, Oncology, Hematology
Alıntı
Ali, R. vd. (2007). "Aspergillosis osteomyelitis and joint infection in a renal transplant recipient". Leukemia & Lymphoma, 48(7), 1426-1428.